Showing results (21-30 of 85) with videos related to
Sort By:
Pageof 9
Dermatology and Therapy|October 4, 2024
Matching-Adjusted Indirect Comparison of the Efficacy and Safety of Difamilast 1% and Delgocitinib 0.5% in Patients with Moderate-to-Severe Atopic DermatitisTakeshi Nakahara, Hiroyuki Murota, Miyuki Matsukawa, et al.Dermatology and Therapy|November 2, 2024
Cost-Effectiveness Study of Difamilast 1% for the Treatment of Atopic Dermatitis in Adult Japanese PatientsTakeshi Nakahara, Shinichi Noto, Miyuki Matsukawa, et al.Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|October 14, 2003
Expression of RHOC is associated with metastasis of gastric carcinomasTomohiro Kondo, Kazuhiro Sentani, Naohide Oue, et al.Mammalian Genome : Official Journal of the International Mammalian Genome Society|July 2, 2016
A novel spontaneous mutation of BCAR3 results in extrusion cataracts in CF#1 mouse strainTomohiro Kondo, Taketo Nakamori, Hiroaki Nagai, et al.Journal of Reproductive Immunology|May 11, 2010
DNA microarray analysis in a mouse model for endometriosis and validation of candidate factors with human adenomyosisKen Takeshi Kusakabe, Hideaki Abe, Tomohiro Kondo, et al.Molecular and Clinical Oncology|January 21, 2017
Conversion therapy of gastric cancer with massive malignant ascites and ovarian metastases by systemic and intraperitoneal chemotherapyTomohiro Kondo, Hiromitsu Kitayama, Junko Sugiyama, et al.Optics Letters|April 2, 2014
Reflection characteristics of guided-mode resonance filter combined with bottom mirrorJunichi Inoue, Tomonori Ogura, Tomohiro Kondo, et al.Cancer Research|January 28, 2004
Expression of POT1 is associated with tumor stage and telomere length in gastric carcinomaTomohiro Kondo, Naohide Oue, Kazuhiro Yoshida, et al.BMC Cancer|May 21, 2017
Venous thromboembolism in hospitalized patients receiving chemotherapy for malignancies at Japanese community hospital: prospective observational studyHiromitsu Kitayama, Tomohiro Kondo, Junko Sugiyama, et al.International Journal of Clinical Oncology|September 1, 2018
Predicting marker for early progression in unresectable melanoma treated with nivolumabTomohiro Kondo, Motoo Nomura, Atsushi Otsuka, et al.Pageof 9